These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
169 related items for PubMed ID: 26292066
21. Discovery of vinylogous carbamates as a novel class of β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors. Li HQ, Luo Y, Zhu HL. Bioorg Med Chem; 2011 Aug 01; 19(15):4454-9. PubMed ID: 21742506 [Abstract] [Full Text] [Related]
22. Novel E. coli beta-ketoacyl-acyl carrier protein synthase III inhibitors as targeted antibiotics. Lee JY, Jeong KW, Lee JU, Kang DI, Kim Y. Bioorg Med Chem; 2009 Feb 15; 17(4):1506-13. PubMed ID: 19185501 [Abstract] [Full Text] [Related]
23. Beta-ketoacyl-acyl carrier protein synthase III from pea (Pisum sativum L.): properties, inhibition by a novel thiolactomycin analogue and isolation of a cDNA clone encoding the enzyme. Jones AL, Gane AM, Herbert D, Willey DL, Rutter AJ, Kille P, Dancer JE, Harwood JL. Planta; 2003 Mar 15; 216(5):752-61. PubMed ID: 12624762 [Abstract] [Full Text] [Related]
24. Crystal structure of beta-ketoacyl-acyl carrier protein synthase III. A key condensing enzyme in bacterial fatty acid biosynthesis. Qiu X, Janson CA, Konstantinidis AK, Nwagwu S, Silverman C, Smith WW, Khandekar S, Lonsdale J, Abdel-Meguid SS. J Biol Chem; 1999 Dec 17; 274(51):36465-71. PubMed ID: 10593943 [Abstract] [Full Text] [Related]
25. Molecular cloning of a cDNA encoding 3-ketoacyl-acyl carrier protein synthase III from leek. Chen J, Post-Beittenmiller D. Gene; 1996 Dec 05; 182(1-2):45-52. PubMed ID: 8982066 [Abstract] [Full Text] [Related]
27. Slow onset inhibition of bacterial beta-ketoacyl-acyl carrier protein synthases by thiolactomycin. Machutta CA, Bommineni GR, Luckner SR, Kapilashrami K, Ruzsicska B, Simmerling C, Kisker C, Tonge PJ. J Biol Chem; 2010 Feb 26; 285(9):6161-9. PubMed ID: 20018879 [Abstract] [Full Text] [Related]
28. Synthesis and antibacterial activity of cinnamaldehyde acylhydrazone with a 1,4-benzodioxan fragment as a novel class of potent β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitor. Song X, Yang Y, Zhao J, Chen Y. Chem Pharm Bull (Tokyo); 2014 Feb 26; 62(11):1110-8. PubMed ID: 25196128 [Abstract] [Full Text] [Related]
29. beta-Ketoacyl-[acyl carrier protein] synthase I of Escherichia coli: aspects of the condensation mechanism revealed by analyses of mutations in the active site pocket. McGuire KA, Siggaard-Andersen M, Bangera MG, Olsen JG, von Wettstein-Knowles P. Biochemistry; 2001 Aug 21; 40(33):9836-45. PubMed ID: 11502177 [Abstract] [Full Text] [Related]
30. Homology modeling and docking studies of FabH (β-ketoacyl-ACP synthase III) enzyme involved in type II fatty acid biosynthesis of Chlorella variabilis: a potential algal feedstock for biofuel production. Misra N, Patra MC, Panda PK, Sukla LB, Mishra BK. J Biomol Struct Dyn; 2013 Mar 21; 31(3):241-57. PubMed ID: 22830394 [Abstract] [Full Text] [Related]
31. The role of beta-ketoacyl-acyl carrier protein synthase III in the condensation steps of fatty acid biosynthesis in sunflower. González-Mellado D, von Wettstein-Knowles P, Garcés R, Martínez-Force E. Planta; 2010 May 21; 231(6):1277-89. PubMed ID: 20221630 [Abstract] [Full Text] [Related]
32. Design and synthesis of potent inhibitors of beta-ketoacyl-acyl carrier protein synthase III (FabH) as potential antibacterial agents. Shi L, Fang RQ, Zhu ZW, Yang Y, Cheng K, Zhong WQ, Zhu HL. Eur J Med Chem; 2010 Sep 21; 45(9):4358-64. PubMed ID: 20557983 [Abstract] [Full Text] [Related]
33. Discovery of novel bacterial elongation condensing enzyme inhibitors by virtual screening. Zheng Z, Parsons JB, Tangallapally R, Zhang W, Rock CO, Lee RE. Bioorg Med Chem Lett; 2014 Jun 01; 24(11):2585-8. PubMed ID: 24755430 [Abstract] [Full Text] [Related]
34. Beta-ketoacyl-acyl carrier protein synthase III (FabH) is essential for bacterial fatty acid synthesis. Lai CY, Cronan JE. J Biol Chem; 2003 Dec 19; 278(51):51494-503. PubMed ID: 14523010 [Abstract] [Full Text] [Related]
35. Structural Characterisation of the Beta-Ketoacyl-Acyl Carrier Protein Synthases, FabF and FabH, of Yersinia pestis. Nanson JD, Himiari Z, Swarbrick CM, Forwood JK. Sci Rep; 2015 Oct 15; 5():14797. PubMed ID: 26469877 [Abstract] [Full Text] [Related]
36. Discovery of novel selective inhibitors of Staphylococcus aureus β-ketoacyl acyl carrier protein synthase III. Lee JY, Jeong KW, Shin S, Lee JU, Kim Y. Eur J Med Chem; 2012 Jan 15; 47(1):261-9. PubMed ID: 22104972 [Abstract] [Full Text] [Related]
37. Structure-assisted discovery of an aminothiazole derivative as a lead molecule for inhibition of bacterial fatty-acid synthesis. Pappenberger G, Schulz-Gasch T, Kusznir E, Müller F, Hennig M. Acta Crystallogr D Biol Crystallogr; 2007 Dec 15; 63(Pt 12):1208-16. PubMed ID: 18084068 [Abstract] [Full Text] [Related]
38. Study of Schiff-Base-Derived with Dioxygenated Rings and Nitrogen Heterocycle as Potential β-Ketoacyl-acyl Carrier Protein Synthase III (FabH) Inhibitors. Zhou Y, Yang YS, Song XD, Lu L, Zhu HL. Chem Pharm Bull (Tokyo); 2017 Dec 15; 65(2):178-185. PubMed ID: 28154310 [Abstract] [Full Text] [Related]
39. Deciphering the Binding Interactions between Acinetobacter baumannii ACP and β-ketoacyl ACP Synthase III to Improve Antibiotic Targeting Using NMR Spectroscopy. Choi S, Park J, Yeon J, Jang A, Lee WC, Kim Y. Int J Mol Sci; 2021 Mar 24; 22(7):. PubMed ID: 33805050 [Abstract] [Full Text] [Related]
40. Design, synthesis and biological evaluation of urea derivatives from o-hydroxybenzylamines and phenylisocyanate as potential FabH inhibitors. Li ZL, Li QS, Zhang HJ, Hu Y, Zhu DD, Zhu HL. Bioorg Med Chem; 2011 Aug 01; 19(15):4413-20. PubMed ID: 21752655 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]